Prosecution Insights
Last updated: October 25, 2026

Board of Trustees of Michigan State University

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

24 pending office actions • 22 art units • 24 examiners • 0 of 24 (0%) have an AI response strategy ready • 23 patents granted in the last 365 days

Analysis

Board of Trustees of Michigan State University has 24 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 24 distinct examiners and 22 art units, indicating wide dispersion across examination personnel and technical classifications.

MOWLA, GOLAM is the busiest examiner, with 1 pending action. The data shows no repeated examiner assignment, so counsel should rely on coordinated docket systems rather than a concentrated examiner strategy. Technical grouping and consistent handling of biotechnology evidence may help manage the separate prosecution records.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

24
Total Pending OAs
16
Non-Final OAs
7
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (1)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

15
Hard (62%)
6
Medium (25%)
2
Easy (8%)
1
Unknown (4%)

Rejection Statute Mix

BucketCases
§101 + other5 (21%)
§103 only3 (12%)
§102 only1 (4%)
§112 only2 (8%)
Double-patenting + other2 (8%)
Multi-statute (no §101)10 (42%)
No statute on record1 (4%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

18
Life Sciences
75% of docket
2
Information Tech
8% of docket
1
Communications
4% of docket
1
Semiconductors
4% of docket
1
Mechanical / Eng
4% of docket
1
Business / Other
4% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

240 h
Manual time on pending OAs
48 h
Time saved (low, 20%)
84 h
Time saved (mid, 35%)
2.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MOWLA, GOLAM 1 62.1% +28.0%
HINES, JANA A 1 53.2% +39.4%
GOLOBOY, JAMES C 1 63.7% +8.7%
BORGEEST, CHRISTINA M 1 55.7% +21.4%
BURKE, MATTHEW RYAN 1 0.0% +0.0%
SRIRAM, ADITYA 1 73.9% +22.1%
STEPHENS, REBECCA JOHANNA 1 68.2% +27.7%
KNOWLAN, KEVIN MICHAEL 1 100.0% +0.0%
OTTON, ALICIA L 1 65.0% +9.3%
MIGGINS, MICHAEL C 1 80.8% +16.6%

Hard Cases (15)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17998128 SYSTEMS AND METHODS FOR TREATING LEVODOPA DYSKINESIA, ENHANCING MOTOR BENEFIT, AND DELAYING DISEASE PROGRESSION ANGELL, JON E 4d overdue
17637440 SYSTEM AND METHODS FOR ELECTROSTATIC ANALYSIS WITH MACHINE LEARNING MODEL LUO, JAMMY NMN 3d overdue
17423289 COMPOSITIONS AND METHODS FOR IMMUNE MODULATION AND TREATMENT OF CANCER HEITMEIER, KENDALL NICOLE 2d overdue
18730004 SYSTEM AND METHOD FOR METAMAKING AND METAVERSE RIGHTS MANAGEMENT SRIRAM, ADITYA 84d
19211664 FUNCTIONALIZED MAGNETIC PARTICLE COMPOSITIONS AND RELATED METHODS HINES, JANA A —
18800360 METHODS AND COMPOSITIONS FOR SIRT1 EXPRESSION AS A MARKER FOR ENDOMETRIOSIS AND SUBFERTILITY BORGEEST, CHRISTINA M —
18833687 COMPOSITIONS COMPRISING A BIOABSORBABLE POLYMER AND METABOLIC INHIBITOR BURKE, MATTHEW RYAN —
18768941 OVERCOMING SELF-INCOMPATIBILITY IN DIPLOID PLANTS FOR BREEDING AND PRODUCTION OF HYBRIDS STEPHENS, REBECCA JOHANNA —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18730004 SYSTEM AND METHOD FOR METAMAKING AND METAVERSE RIGHTS MANAGEMENT SRIRAM, ADITYA 84d
19227998 Transparent Luminescent Solar Concentrator MOWLA, GOLAM —
19211664 FUNCTIONALIZED MAGNETIC PARTICLE COMPOSITIONS AND RELATED METHODS HINES, JANA A —
18800360 METHODS AND COMPOSITIONS FOR SIRT1 EXPRESSION AS A MARKER FOR ENDOMETRIOSIS AND SUBFERTILITY BORGEEST, CHRISTINA M —
18768941 OVERCOMING SELF-INCOMPATIBILITY IN DIPLOID PLANTS FOR BREEDING AND PRODUCTION OF HYBRIDS STEPHENS, REBECCA JOHANNA —
18580263 POLYESTER MULTILAYER PLASTICS AND RELATED METHODS MIGGINS, MICHAEL C —

Top Art Units

Art UnitApps
1663 2
1621 2
1721 1
1645 1
1771 1
1675 1
1619 1
2491 1
1783 1
1699 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19227998 Transparent Luminescent Solar Concentrator MOWLA, GOLAM 1721 §102§103DP Final Rejection — Pending Jun 04, 2025
19211664 FUNCTIONALIZED MAGNETIC PARTICLE COMPOSITIONS AND RELATED METHODS HINES, JANA A 1645 §102§103 Non-Final OA — Pending May 19, 2025
18858436 OXIDATION REACTOR FOR SOLID SOLAR THERMOCHEMICAL FUEL GOLOBOY, JAMES C 1771 §102 Non-Final OA — Pending Oct 21, 2024
18800360 METHODS AND COMPOSITIONS FOR SIRT1 EXPRESSION AS A MARKER FOR ENDOMETRIOSIS AND SUBFERTILITY BORGEEST, CHRISTINA M 1675 §101§103§112DP Non-Final OA — Pending Aug 12, 2024
18833687 COMPOSITIONS COMPRISING A BIOABSORBABLE POLYMER AND METABOLIC INHIBITOR BURKE, MATTHEW RYAN 1619 §102§103§112Other Non-Final OA — Pending Jul 26, 2024
18730004 SYSTEM AND METHOD FOR METAMAKING AND METAVERSE RIGHTS MANAGEMENT SRIRAM, ADITYA 2491 §101§103§112 Non-Final OA 84d Pending Jul 18, 2024
18768941 OVERCOMING SELF-INCOMPATIBILITY IN DIPLOID PLANTS FOR BREEDING AND PRODUCTION OF HYBRIDS STEPHENS, REBECCA JOHANNA 1663 §102§103 Non-Final OA — Pending Jul 10, 2024
18708156 Pyridinium Compounds With Low Reduction Potentials And Persistent Radical States KNOWLAN, KEVIN MICHAEL 1783 §102§103§112 Non-Final OA — Pending May 07, 2024
18634344 Soluble Epoxide Hydrolase Inhibitors and Use Thereof OTTON, ALICIA L 1699 §102§112DPOther Non-Final OA — Pending Apr 12, 2024
18580263 POLYESTER MULTILAYER PLASTICS AND RELATED METHODS MIGGINS, MICHAEL C 1782 §102§103 Non-Final OA — Pending Jan 18, 2024
18566824 HYBRID BIOINK BIOMATERIAL ILLING, CAITLIN NORINE 1767 §103 Non-Final OA — Pending Dec 04, 2023
18378230 Soft Pressure Sensor Array HOPKINS, BRANDI N 2857 §102§103 Non-Final OA — Pending Oct 10, 2023
18367079 OMNIPHOBIC COMPOSITION CONCENTRATES, RELATED ARTICLES, AND RELATED METHODS DARLING, DEVIN MITCHELL 1764 §112 Final Rejection — Pending Sep 12, 2023
18278200 REACTIVE FUNCTIONALIZATION OF CARBON-CARBON BACKBONE POLYMERS AND RELATED COMPOSITIONS FEELY, MICHAEL J 1766 §103§112 Non-Final OA — Pending Aug 22, 2023
18274705 THERAPEUTIC COMPOUNDS AND USES THEREOF RODRIGUEZ-GARCIA, VALERIE 1621 §102§103§112 Non-Final OA — Pending Jul 27, 2023
18357767 PRODUCTION OF DITERPENE ALKALOIDS SPEED, DEQUANTARIUS JAVON 1663 §112 Non-Final OA 43d overdue Pending Jul 24, 2023
18351624 SURFACE TREATMENT OF CARBON FIBER EPOXY COMPOSITES THROUGH DIAZONIUM ADMOLECULE MODIFICATION SYLVESTER, KEVIN 1794 §103 Final Rejection 9d Pending Jul 13, 2023
18218371 DNA ENCODING RING ZINC-FINGER PROTEIN AND THE USE OF THE DNA IN VECTORS AND BACTERIA AND IN PLANTS DRISCOLL, LORA E BARNHART 3991 Other Non-Final OA — Pending Jul 05, 2023
18256891 REDUCTION OF NITROGEN GREENHOUSE GAS EMISSIONS IN AGROECOSYSTEMS FOR PRECISION CONSERVATION PRASAD, NANCY N 3624 §101§103 Non-Final OA — Pending Jun 09, 2023
17926916 SYSTEMS AND METHODS FOR AUTOMATIC AND NONINVASIVE LIVESTOCK HEALTH ANALYSIS HAILE, BENYAM 2688 §103 Final Rejection 34d Pending Nov 21, 2022
17998128 SYSTEMS AND METHODS FOR TREATING LEVODOPA DYSKINESIA, ENHANCING MOTOR BENEFIT, AND DELAYING DISEASE PROGRESSION ANGELL, JON E 1637 §102§103 Final Rejection 4d overdue Pending Nov 07, 2022
17763989 METHODS AND COMPOSITIONS FOR TREATING DIABETIC RETINOPATHY FONTAINHAS, AURORA M 1600 §101§103§112Other Non-Final OA — Pending Mar 25, 2022
17637440 SYSTEM AND METHODS FOR ELECTROSTATIC ANALYSIS WITH MACHINE LEARNING MODEL LUO, JAMMY NMN 2151 §101§103 Final Rejection 3d overdue Pending Feb 22, 2022
17423289 COMPOSITIONS AND METHODS FOR IMMUNE MODULATION AND TREATMENT OF CANCER HEITMEIER, KENDALL NICOLE 1621 §102§103§112Other Final Rejection 2d overdue Pending Jul 15, 2021

Managing Board of Trustees of Michigan State University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Board of Trustees of Michigan State University have?

Board of Trustees of Michigan State University has 24 pending office actions as of October 2026, spread across 22 art units and 24 examiners.

Which USPTO examiner handles the most Board of Trustees of Michigan State University applications?

Golam Mowla has the most, with 1 of Board of Trustees of Michigan State University's pending office actions.

What technology area are Board of Trustees of Michigan State University's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month